STACY SVEEN: Open Payments
NPI 1962069310 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 15 payments from 7 companies in 2025. Trend: 2023 $437 · 2024 $1,789 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $125 |
| Amgen Inc. | 3 | $98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $96 |
| Medtronic, Inc. | 5 | $93 |
| E.R. Squibb & Sons, L.L.C. | 3 | $44 |
| ABIOMED | 1 | $38 |
| Boston Scientific Corporation | 1 | $22 |
Products named: Wegovy, JARDIANCE, SYMPLICITY G3, CAMZYOS, REPATHA, WATCHMAN FLX, COMPLETE SE VASCULAR.
Industry payments across NE — which companies pay providers there.
